Efficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: Further analyses from the LUME-Lung 1 study
Heigener, D., Gottfried, M., Bennouna, J., Bondarenko, I., Douillard, J-Y., Krzakowski, M., Mellemgaard, A., Novello, S., Orlov, S., Summers, Y.J., von Pawel, J., Hocke, J., Kaiser, R., Reck, M.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.76
Date:
October, 2016
File:
PDF, 42 KB
english, 2016